Now Available! | Check out UMR’s 2024 Annual Economic Report and State Toolkits today
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Rural State Analysis | UMR's 2023 Report Reveals the Exponential Impact of NIH Research Funding in 7 Rural States
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Becton Dickson is the NJ-based syringe manufacturer that stepped up to take on COVID-19

In the early stages of the COVID pandemic, as most of the world sought hope amid soaring death tolls and sinking economies, a New Jersey company looked ahead and readied itself for the moment when a medical solution would arrive. Anticipating the development of vaccines as well as a red-hot worldwide demand for its products, Becton Dickinson, the world′s leading syringe manufacturer, ramped up production at plants in the U.S., Asia, and Europe early in 2020. Hundreds of millions of orders poured in from across the globe and in response, the Franklin Lakes-based company produced 1 billion more needles and syringes than in a typical year, an increase of more than 2,000 a minute.